To clarify whether rhein played its regulatory role via the NFATc1/Trem2 axis in vivo, the ARDS model was established with the administration of an NFATc1 blocker (NFATc1-IN-1). The gene discussed is NFATC1; the disease is acute respiratory distress syndrome.